Search Results 621-630 of 18259 for SARS

1. A Study to Compare BAL CD8+ TRM Cells and Lung Fibrosis Scores in COVID-19 Infection Survivors - Mayo Clinic

   SARS-CoV-2 infection confirmed by PCR. Need for hospitalization due to COVID-19 pneumonia. Need for ≥ 2L supplemental oxygen at any point during ...

2. Advances in sports medicine emerging from Mayo Clinic Health System and collaborators

   Many researchers shifted their focus almost entirely to SARS-CoV-2 and COVID-19 – looking for ways to detect, treat and prevent infection, while some projects ...

3. Publications - William G. Morice, II, M.D., Ph.D. - Mayo Clinic

   ... SARS-CoV-2 Spike-Targeted Serology. Popul Health Manag. 2023 Feb; 26 (1):29-36. View PubMed; Vachon CM, Norman AD, Prasad K, Jensen D, Schaeferle GM, Vierling ...

4. Respiratory Failure Clinical Trials - Mayo Clinic Research

   ... SARS-CoV-2 as compared to SOC treatment with placebo. . Mayo Clinic Footer. Request Appointment · Give Now · Contact Us · About Mayo Clinic · Employees · Site ...

5. Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial - Mayo Clinic

   including known SARS-CoV2 infections regardless of symptoms. - Known allergy to Nitinol or nickel sensitivity. - Known medical condition with expected ...

6. Aids Clinical Trials - Mayo Clinic Research

   The purpose of this study is to better understand the role of HIV and/or HCV infection and/or SARS-CoV-2 on the immune system and potential ways to ...

7. Phase 2 Study Of Inhaled SNG001 In Mechanically Ventilated Patients With Respiratory Viral Infection - Mayo Clinic

   ... SARS-COV-2 and seasonal coronaviruses) in a nose swab sample, confirmed by a positive virus test using a Sponsor approved rapid POC test (e.g., reverse ...

8. COVID-19 and Acute Renal Failure - Mayo Clinic

   Patients testing positive for SARS-CoV-2 and requiring hospitalization at the Mayo Clinic Arizona, Rochester, or Florida campuses. Exclusion Criteria ...

9. Home Screening for COVID-19 - Clinical Trials

   Current or previous within 2 months infection to SARS-CoV-2. No compatible smartphone to connect and run the AliveCor system (https://store.alivecor.com ...

10. A Study to Investigate Intravenous Tocilizumab in Patients with Moderate-to-Severe COVID-19 Pneumonia (enrolling by invitation only) - Mayo Clinic

    Suspected active bacterial, fungal, viral, or other infection (besides SARS-CoV-2);; Patients who are on a mechanical ventilator > 24 hours or ECMO, in shock ...